Colgate’s 63-Year Dividend Streak Hides in Plain Sight
Colgate-Palmolive just quietly extended a dividend streak that outlasts nearly every business on earth: 63 consecutive years of increases, with uninterrupted payouts stretching back to 1895. That’s not a typo — investors buying the stock today are collecting checks from a company that was paying dividends before the Wright brothers flew. For patient, income-focused investors, that kind of institutional durability is worth far more attention than it currently gets.
The numbers behind the streak are what make it credible rather than merely nostalgic. Second-quarter net sales rose 4.9% to $5.36 billion, and Base Business earnings per share climbed 8% to $0.99, with gross margin expanding 140 basis points to 61.5%. More importantly for dividend sustainability: operating cash flow hit $1.74 billion in the first half of 2026, up from $1.48 billion a year earlier, while the company paid out $879 million in dividends over the same stretch. Free cash flow covered the payout with room to spare — the single most important metric for anyone betting on a dividend lasting another decade, let alone another century.
Colgate’s moat is unglamorous but effective: 41.3% global toothpaste market share and 32.7% of the manual toothbrush market, built on products people buy on autopilot regardless of economic conditions. Organic sales growth of just 2.4% (and a 3% decline in North America) explains why the stock doesn’t excite growth investors — there’s no AI angle, no re-rating story, no double-digit yield to chase. Management held its 2026 outlook steady at mid-single-digit Base Business EPS growth, hardly headline material.
So what for long-term investors: this is precisely the kind of “boring” compounder that gets ignored while capital chases flashier names, yet it’s the type of holding that quietly does the heavy lifting in a diversified portfolio over 20-30 year horizons. A 63-year dividend growth streak isn’t luck — it reflects pricing power, brand loyalty, and disciplined capital allocation that survive recessions, pandemics, and management changes alike. Investors focused on total return rather than this quarter’s growth rate may find more value in Colgate’s consistency than in whatever is dominating headlines this week.
